NCT01037790 2021-03-11Phase II Trial of the Cyclin-Dependent Kinase Inhibitor PD 0332991 in Patients With CancerAbramson Cancer Center at Penn MedicinePhase 2 Completed304 enrolled 12 charts
NCT01806675 2019-10-0318F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyStanford UniversityPhase 1/2 Completed25 enrolled 14 charts
NCT00538850 2014-03-05Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer PainINSYS Therapeutics IncPhase 3 Completed130 enrolled 9 charts